2m 2m 2m 2m 2m 2m 2m
Pediatrix Medica (MD)
NYSE
$23.86+$0.34 (+1.45%)
Price as of Jun 23, 2026 4:10 PM EDT- $1.9BMarket Cap
- 75.92%1-Year Change
- Medical Care FacilitiesIndustry
Pediatrix Medica (MD)
$23.86+$0.34 (+1.45%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 1.7M +47.07% | 1.1M -24.85% | 1.5M +130.11% | -5.1M -100.26% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 1.7M +47.07% | 1.1M -24.85% | 1.5M +130.11% | -5.1M -100.26% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 21.8M -32.27% | 32.2M -10.91% | 36.2M +1.50% | 35.6M +10.85% | |
Total Operating Expenses | 1.7B -18.09% | 2.1B +4.75% | 2.0B +10.45% | 1.8B +5.33% | |
Operating Profit | 208.8M +403.89% | -68.7M -1,038.57% | 7.3M -95.76% | 172.7M -14.90% | |
Interest Income | 20.9M N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | -42.1M +6.00% | -39.7M -42.24% | |
Interest Income and Expense and Net | 20.9M N/A | 0 +100.00% | -42.1M +6.00% | -39.7M -42.24% | |
Total Nonoperating Income and Expense | 7.6M +123.35% | -32.6M -41.40% | -55.7M -39.03% | -91.3M +34.91% | |
Income before Taxes | 216.4M +313.57% | -101.3M +109.56% | -48.4M -159.43% | 81.4M -39.83% | |
Income Taxes | 51.0M +2,346.65% | -2.3M -118.86% | 12.0M -35.93% | 18.8M -30.96% | |
Extraordinary Items | N/A N/A | 0 -100.00% | 20.0M N/A | N/A N/A | |
Net Income | 165.4M +266.94% | -99.1M +64.00% | -60.4M -191.07% | 66.3M -49.35% | |
Net Income from Continuing Operations Applicable to Common | 216.4M +313.57% | -101.3M +109.56% | -48.4M -159.43% | 81.4M -39.83% | |
Basic EPS and Net Income | 1.97 +265.55% | -1.19 -263.01% | 0.73 -7.59% | 0.79 -48.70% | |
Diluted EPS and Net Income | 1.94 +263.03% | -1.19 -263.01% | 0.73 -7.59% | 0.79 -48.37% | |
Basic Weighted Average Shares | 84.1M +0.90% | 83.3M +1.37% | 82.2M -1.52% | 83.5M -1.61% | |
Diluted Weighted Average Shares | 85.3M +2.33% | 83.3M +1.37% | 82.2M -2.28% | 84.1M -1.99% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 375.2M +63.19% | 229.9M +213.88% | 73.3M +645.70% | 9.8M -97.46% | |
Short-Term Investments | 124.5M +4.99% | 118.6M +13.48% | 104.5M +12.06% | 93.2M -6.49% | |
Cash and Cash Equivalents and Short-Term Investments | 499.7M +43.39% | 348.5M +96.07% | 177.7M +72.46% | 103.1M -78.84% | |
Total Current Assets | 763.5M +19.37% | 639.6M +32.30% | 483.5M +12.96% | 428.0M -49.08% | |
Accumulated Depreciation | 132.3M +4.61% | 126.5M -11.36% | 142.7M -17.13% | 172.2M +4.57% | |
Property and Plant and Equipment and Net | 39.2M +0.02% | 39.2M -48.21% | 75.6M +3.21% | 73.3M +4.47% | |
Total Long-Term Assets | 58.2M -24.08% | 76.6M -6.78% | 82.2M -33.29% | 123.2M -5.99% | |
Total Assets | 2.2B +4.37% | 2.2B -3.02% | 2.2B -5.45% | 2.3B -13.76% | |
Income Taxes Payable | 58.0M +59.29% | 36.4M -0.14% | 36.5M -26.93% | 49.9M -4.90% | |
Total Short-Term Debt | 26.8M +30.47% | 20.5M +37.77% | 14.9M -21.09% | 18.9M N/A | |
Total Current Liabilities | 458.9M +5.71% | 434.1M +11.61% | 388.9M -8.91% | 427.0M -0.09% | |
Total Long-Term Debt | 570.5M -4.45% | 597.1M -3.44% | 618.4M -64.40% | 1.7B -12.69% | |
Total Long-Term Liabilities | 30.3M -7.76% | 32.9M +7.64% | 30.6M -22.48% | 39.4M -6.90% | |
Total Liabilities | 1.4B -0.50% | 1.4B +1.24% | 1.4B -5.87% | 1.5B -20.24% | |
Retained Earnings | -83.2M -66.54% | -248.5M -266.28% | 149.5M +267.83% | -89.1M -42.68% | |
Total Stockholders Equity | 865.9M +13.19% | 764.9M -9.91% | 849.1M -4.77% | 891.6M -0.54% | |
Total Shares Outstanding | 83.0M -3.37% | 85.9M +2.20% | 84.0M +1.29% | 82.9M -3.09% | |
Cash Flow | |||||
Cash from Operating Activities | 271.1M +31.23% | 206.6M +50.43% | 137.3M -17.74% | 166.9M +117.55% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | -18.3M -48.33% | -35.4M -26.51% | -48.2M -15.41% | -57.0M +7.31% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -107.5M +642.11% | -14.5M -43.67% | -25.7M -94.73% | -487.6M -35.86% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | 12,421.95% +306.63% | -6,011.64% -1,348.97% | 481.33% +114.08% | -3,418.89% -32,300.80% | |
Return on Assets | 7.52% +265.92% | -4.53% +71.32% | -2.64% -201.09% | 2.62% -39.36% | |
Return on Equity | 20.28% +265.22% | -12.28% +76.87% | -6.94% -193.55% | 7.42% -53.43% | |
Revenue Growth | 47.07% +289.40% | -24.85% -119.10% | 130.11% +229.77% | -100.26% -1,080.90% | |
Current Ratio | 1.66 +12.92% | 1.47 +18.54% | 1.24 +24.00% | 1.00 -49.03% | |
Cash Ratio | 0.82 +54.37% | 0.53 +181.16% | 0.19 +719.13% | 0.02 -97.46% | |
Debt-to-Equity Ratio | 0.69 -14.56% | 0.81 +8.26% | 0.75 -62.13% | 1.97 N/A | |
Debt-to-Assets Ratio | 0.27 -7.32% | 0.29 +0.56% | 0.29 -61.85% | 0.75 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow